These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11026004)

  • 1. [Paclitaxel for treatment of advanced breast cancers].
    Ito Y
    Nihon Rinsho; 2000 Apr; 58 Suppl():259-64. PubMed ID: 11026004
    [No Abstract]   [Full Text] [Related]  

  • 2. [Docetaxel hydrate for treatment of advanced breast cancers].
    Fujii H
    Nihon Rinsho; 2000 Apr; 58 Suppl():254-8. PubMed ID: 11026003
    [No Abstract]   [Full Text] [Related]  

  • 3. HER2 and response to paclitaxel in node-positive breast cancer.
    Roukos DH
    N Engl J Med; 2008 Jan; 358(2):197; author reply 198. PubMed ID: 18193530
    [No Abstract]   [Full Text] [Related]  

  • 4. HER2 and response to paclitaxel in node-positive breast cancer.
    Ferretti G; Felici A; Cognetti F
    N Engl J Med; 2008 Jan; 358(2):197; author reply 198. PubMed ID: 18184969
    [No Abstract]   [Full Text] [Related]  

  • 5. HER2 and response to paclitaxel in node-positive breast cancer.
    Nash I
    N Engl J Med; 2008 Jan; 358(2):198; author reply 198-9. PubMed ID: 18193532
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiac dysfunction in cancer patients receiving paclitaxel.
    Valdés Olmos RA; ten Bokkel Huinink WW; Hoefnagel CA
    Eur J Nucl Med; 1998 Apr; 25(4):446-7. PubMed ID: 9643974
    [No Abstract]   [Full Text] [Related]  

  • 7. [Weekly administration of paclitaxel in the treatment of metastatic breast cancer: from rational to practice].
    Campone M; Fumoleau P
    Bull Cancer; 2002 Mar; 89(3):275-82. PubMed ID: 11940467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genentech's anticancer Mab expected by November.
    Robertson D
    Nat Biotechnol; 1998 Jul; 16(7):615. PubMed ID: 9661186
    [No Abstract]   [Full Text] [Related]  

  • 9. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
    Holmes FA
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of paclitaxel in the treatment of breast cancer: the American Cooperative Group Experience.
    Sledge GW
    Semin Oncol; 1996 Feb; 23(1 Suppl 1):10-2. PubMed ID: 8629029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.
    Amadori D; Frassineti GL; Zoli W; Milandri C; Tienghi A; Ravaioli A; Gentile A; Salzano E
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):16-22. PubMed ID: 8893894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes.
    Hudis CA; Seidman AD; Baselga J; Raptis G; Lebwohl D; Gilewski T; Currie V; Moynahan ME; Sklarin N; Fennelly D
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):18-23. PubMed ID: 8643965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trastuzumab combined with paclitaxel after doxorubicin and cyclophosphamide for operable HER2-positive breast cancer.
    Ferretti G; Felici A; Papaldo P; Carlini P; Fabi A; Cognetti F
    Oncologist; 2006 May; 11(5):533; author reply 534. PubMed ID: 16720857
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of metastatic breast cancer with paclitaxel and doxorubicin.
    Dombernowsky P; Gehl J; Boesgaard M; Jensen TP; Jensen BW; Ejlertsen B
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):13-7. PubMed ID: 8643964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Trastuzumab for treatment of advanced breast cancers].
    Watanabe T; Shimizu C; Katsumata N; Saijo N
    Nihon Rinsho; 2000 Apr; 58 Suppl():340-4. PubMed ID: 11026016
    [No Abstract]   [Full Text] [Related]  

  • 16. [Paclitaxel].
    Díaz M; Campanero MA
    Rev Med Univ Navarra; 1996; 40(3):43-51. PubMed ID: 9499826
    [No Abstract]   [Full Text] [Related]  

  • 17. Doxorubicin and paclitaxel, a highly active combination in the treatment of metastatic breast cancer.
    Dombernowsky P; Gehl J; Boesgaard M; Paaske T; Jensen BV
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):23-7. PubMed ID: 8893895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin/paclitaxel combination does not expose breast cancer patients to excessive cardiac risk.
    Oncology (Williston Park); 2001 Jul; 15(7):830. PubMed ID: 11499684
    [No Abstract]   [Full Text] [Related]  

  • 19. Nonpegylated liposomal doxorubicin (TLC-D99), paclitaxel, and trastuzumab in HER-2-overexpressing breast cancer: a multicenter phase I/II study.
    Cortes J; Di Cosimo S; Climent MA; Cortés-Funes H; Lluch A; Gascón P; Mayordomo JI; Gil M; Benavides M; Cirera L; Ojeda B; Rodríguez CA; Trigo JM; Vazquez J; Regueiro P; Dorado JF; Baselga J;
    Clin Cancer Res; 2009 Jan; 15(1):307-14. PubMed ID: 19118059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified resistance to chemotherapy and trastuzumab by bevacizumab in locally recurrent breast cancer.
    Farhat MH; El-Saghir NS; Shamseddine AI
    Breast; 2009 Feb; 18(1):66-8. PubMed ID: 19013064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.